ILK and adenocarcinoma: Similar to the AOM/DSS model, the proportion of APCmin/+ -driven tumours that progressed to high-grade adenocarcinomas was reduced in myeloid-ILK deficient APCmin/+ mice compared to the WT control (Figure 2E).